IT1209953B - Derivati di 1,4-diidro-4-ossonaftiridina e relativi sali, procedimento per la loro produzione e agenti antibatterici che comprendono i medesimi - Google Patents

Derivati di 1,4-diidro-4-ossonaftiridina e relativi sali, procedimento per la loro produzione e agenti antibatterici che comprendono i medesimi

Info

Publication number
IT1209953B
IT1209953B IT8548002A IT4800285A IT1209953B IT 1209953 B IT1209953 B IT 1209953B IT 8548002 A IT8548002 A IT 8548002A IT 4800285 A IT4800285 A IT 4800285A IT 1209953 B IT1209953 B IT 1209953B
Authority
IT
Italy
Prior art keywords
ossonaftyridine
dihydro
derivatives
salts
procedure
Prior art date
Application number
IT8548002A
Other languages
English (en)
Italian (it)
Other versions
IT8548002A0 (it
Inventor
Hirokazu Narita
Yoshinori Konishi
Jun Nitta
Hideyoshi Nagaki
Isao Kitayama
Yoriko Kobayashi
Mikako Shinagawa
Yasuo Watanabe
Akira Yotsuji
Shinzaburo Minami
Isamu Saikawa
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=13845280&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IT1209953(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Publication of IT8548002A0 publication Critical patent/IT8548002A0/it
Application granted granted Critical
Publication of IT1209953B publication Critical patent/IT1209953B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
IT8548002A 1984-04-26 1985-04-26 Derivati di 1,4-diidro-4-ossonaftiridina e relativi sali, procedimento per la loro produzione e agenti antibatterici che comprendono i medesimi IT1209953B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59084963A JPS60228479A (ja) 1984-04-26 1984-04-26 １，４−ジヒドロ−４−オキソナフチリジン誘導体およびその塩

Publications (2)

Publication Number Publication Date
IT8548002A0 IT8548002A0 (it) 1985-04-26
IT1209953B true IT1209953B (it) 1989-08-30

Family

ID=13845280

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8548002A IT1209953B (it) 1984-04-26 1985-04-26 Derivati di 1,4-diidro-4-ossonaftiridina e relativi sali, procedimento per la loro produzione e agenti antibatterici che comprendono i medesimi

Country Status (30)

Country Link
JP (1) JPS60228479A (fr)
KR (1) KR870001693B1 (fr)
AR (1) AR241911A1 (fr)
AT (2) AT389698B (fr)
AU (2) AU565087B2 (fr)
BE (1) BE902279A (fr)
CH (1) CH673458A5 (fr)
CS (1) CS250684B2 (fr)
DD (1) DD238795A5 (fr)
DE (2) DE3546658C2 (fr)
DK (1) DK165877C (fr)
EG (1) EG17339A (fr)
ES (2) ES8700256A1 (fr)
FI (1) FI80453C (fr)
FR (2) FR2563521B1 (fr)
GB (2) GB2158825B (fr)
HU (2) HU194226B (fr)
ID (1) ID21142A (fr)
IL (1) IL75021A (fr)
IT (1) IT1209953B (fr)
LU (1) LU85871A1 (fr)
NL (2) NL187314C (fr)
NO (1) NO162238C (fr)
NZ (1) NZ211895A (fr)
PH (3) PH22801A (fr)
PL (1) PL147392B1 (fr)
PT (1) PT80349B (fr)
RO (2) RO95509B (fr)
SE (2) SE463102B (fr)
ZA (1) ZA853102B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6172753A (ja) * 1984-09-18 1986-04-14 Dainippon Pharmaceut Co Ltd ピリジルケトン誘導体
AT392789B (de) * 1985-01-23 1991-06-10 Toyama Chemical Co Ltd Verfahren zur herstellung von 1-substituierten aryl-1,4-dihydro-4-oxonaphthyridinderivaten
AU576657B2 (en) * 1985-01-23 1988-09-01 Toyama Chemical Co. Ltd. Naphthyridine and pyridine derivatives
DE3525108A1 (de) * 1985-06-07 1986-12-11 Bayer Ag, 5090 Leverkusen Antibakteriell wirksame chinoloncarbonsaeureester
EP0207420B1 (fr) * 1985-06-26 1992-05-06 Daiichi Pharmaceutical Co., Ltd. Dérivés d'acide pyridonecarboxylique
US4962112A (en) * 1987-08-04 1990-10-09 Abbott Laboratories 7-(2-methyl-4-aminopyrrolidinyl)naphthryidine and quinoline compounds
IE62600B1 (en) * 1987-08-04 1995-02-22 Abbott Lab Naphtyridine antianaerobic compounds
US4859776A (en) * 1988-03-11 1989-08-22 Abbott Laboratories (S)-7-(3-aminopyrrolidin-1-yl)-1-(ortho, para-difluorophenyl)-1,4-dihydro-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid and method for its preparation
JP2844079B2 (ja) * 1988-05-23 1999-01-06 塩野義製薬株式会社 ピリドンカルボン酸系抗菌剤
DE3934082A1 (de) * 1989-10-12 1991-04-18 Bayer Ag Chinoloncarbonsaeurederivate, verfahren zu ihrer herstellung sowie ihre verwendung als antivirale mittel
CA2100242A1 (fr) * 1991-01-14 1992-07-15 Soon K. Moon Composes a base de quinolone; methode de preparation
FR2692577B1 (fr) * 1992-05-26 1996-02-02 Bouchara Sa Nouvelles quinolones fluorees, leur procede de preparation et les compositions pharmaceutiques en renfermant.
KR940014395A (ko) * 1992-12-09 1994-07-18 강박광 신규한 퀴놀론 유도체 및 그의 제조방법
KR0148277B1 (ko) * 1993-01-18 1998-11-02 채영복 신규한 플루오르퀴놀론계 유도체 및 그의 제조방법
AU4272793A (en) * 1993-04-24 1994-11-21 Korea Research Institute Of Chemical Technology Novel quinolone carboxylic acid derivatives and process for preparing the same
KR950018003A (ko) * 1993-12-09 1995-07-22 스미스클라인 비참 피엘씨 신규한 퀴놀론 유도체 및 그의 제조 방법
DE69531305T2 (de) * 1994-10-20 2004-05-13 Wakunaga Seiyaku K.K. Pyridoncarboxylat- derivate oder salze davon und antibakterielle zusammensetzungen die diese als aktiven bestandteil enthalten
EP0897919B1 (fr) 1996-04-19 2004-06-16 Wakunaga Pharmaceutical Co., Ltd. Nouveaux derives de l'acide pyridonocarboxylique ou des sels de cet acide et agents antibacteriens contenant ces substances en tant que composant actif
EP0935600A1 (fr) * 1996-10-30 1999-08-18 Bayer Ag Procede de fabrication de composes de naphtyridine et nouveaux produits intermediaires
DE19713506A1 (de) 1997-04-01 1998-10-08 Bayer Ag Verfahren zur Herstellung von 2,6-Dichlor-5-fluornicotinonitril und die chemische Verbindung 3-Cyano-2-hydroxy-5-fluorpyrid-6-on-mononatriumsalz sowie dessen Tautomere
CN1343128B (zh) 1999-03-17 2010-04-21 第一制药株式会社 药物组合物
US6441182B1 (en) 1999-06-10 2002-08-27 Bayer Aktiengesellschaft Method for the production of 2,6-dichloro-5-fluoro-nicotinic acid and coarse and particularly pure 2,6-dichloro-5-fluoro-nicotinic acid
WO2001017991A1 (fr) 1999-09-02 2001-03-15 Wakunaga Pharmaceutical Co., Ltd. Derive d'acide quinolinecarboxylique ou son sel
EP1313708A1 (fr) * 2000-08-29 2003-05-28 Chiron Corporation Composes de quinoline antibacteriens et procedes d'utilisation de ceux-ci
KR100981351B1 (ko) * 2003-10-29 2010-09-10 주식회사 엘지생명과학 7-클로로-1-사이클로프로필-6-플루오로-4-옥소-1,4-디하이드로-1,8-나프티리딘-3-카복실산의 제조방법
CN101792443A (zh) * 2010-03-09 2010-08-04 北京欧凯纳斯科技有限公司 氟代喹诺酮衍生物及其制备方法和用途
JOP20190045A1 (ar) 2016-09-14 2019-03-14 Bayer Ag مركبات أميد حمض 1- أريل-نفثيريدين-3-كربوكسيليك مستبدلة في الموضع 7 واستخدامها.
CN114369092A (zh) * 2021-12-20 2022-04-19 赤峰万泽药业股份有限公司 甲苯磺酸妥舒沙星及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2125310A1 (en) * 1971-05-21 1972-11-30 Sterling Drug Inc , New York, NY (V St A) 1-alkyl-1,4-dihydro-4-oxo-1,8-naphtyridine 3-carboxylic acids antibac
AR223983A1 (es) * 1978-08-25 1981-10-15 Dainippon Pharmaceutical Co Un procedimiento para-preparar derivados de acido 6-halogeno-4-oxo-7-(1-piperazinil)-1,8-naftiridin-3-carboxilico
DE3033157A1 (de) * 1980-09-03 1982-04-01 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
US4382937A (en) 1981-02-27 1983-05-10 Dainippon Pharmaceutical Co., Ltd. Naphthyridine derivatives and their use as anti-bacterials
IE55898B1 (en) * 1982-09-09 1991-02-14 Warner Lambert Co Antibacterial agents
NZ210847A (en) * 1984-01-26 1988-02-29 Abbott Lab Naphthyridine and pyridopyrimidine derivatives and pharmaceutical compositions
IL74064A (en) * 1984-01-26 1988-09-30 Abbott Lab 1,7-disubstituted-1,4-dihydro-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid derivatives and antibacterial compositions containing them
AU576657B2 (en) * 1985-01-23 1988-09-01 Toyama Chemical Co. Ltd. Naphthyridine and pyridine derivatives
DE3525108A1 (de) * 1985-06-07 1986-12-11 Bayer Ag, 5090 Leverkusen Antibakteriell wirksame chinoloncarbonsaeureester

Also Published As

Publication number Publication date
JPS6320828B2 (fr) 1988-04-30
AR241911A1 (es) 1993-01-29
IL75021A0 (en) 1985-08-30
GB2191776B (en) 1990-03-28
PL147392B1 (en) 1989-05-31
NO162238C (no) 1989-12-06
AT389698B (de) 1990-01-10
AU8180487A (en) 1988-03-24
CS250684B2 (en) 1987-05-14
AU565087B2 (en) 1987-09-03
KR870001693B1 (ko) 1987-09-24
FR2614620B1 (fr) 1990-03-09
IL75021A (en) 1994-01-25
HU197571B (en) 1989-04-28
DK185685A (da) 1985-10-27
RO95509A (fr) 1988-09-30
FR2563521B1 (fr) 1989-02-03
KR850007596A (ko) 1985-12-07
FI80453B (fi) 1990-02-28
IT8548002A0 (it) 1985-04-26
SE501412C2 (sv) 1995-02-13
FR2563521A1 (fr) 1985-10-31
HU194226B (en) 1988-01-28
NL9100648A (nl) 1991-08-01
NO162238B (no) 1989-08-21
RO95509B (ro) 1988-10-01
EG17339A (en) 1989-06-30
HUT38634A (en) 1986-06-30
ATA267888A (de) 1989-09-15
GB2158825A (en) 1985-11-20
SE8804586D0 (sv) 1988-12-20
PL253108A1 (en) 1985-12-17
LU85871A1 (fr) 1985-12-16
SE8502017D0 (sv) 1985-04-25
DK185685D0 (da) 1985-04-25
ES8700256A1 (es) 1986-09-16
CH673458A5 (fr) 1990-03-15
GB8716897D0 (en) 1987-08-26
BE902279A (fr) 1985-10-25
PH25228A (en) 1991-03-27
DK165877C (da) 1993-06-21
RO91871A (fr) 1987-07-30
DK165877B (da) 1993-02-01
FI80453C (fi) 1990-06-11
NL187314C (nl) 1991-08-16
NO851643L (no) 1985-10-28
DE3546658C2 (fr) 1992-04-02
SE8502017L (sv) 1985-10-27
ES8706673A1 (es) 1987-07-01
GB2191776A (en) 1987-12-23
ES551538A0 (es) 1987-07-01
PH25046A (en) 1991-01-28
ATA122485A (de) 1989-06-15
PH22801A (en) 1988-12-12
NZ211895A (en) 1988-07-28
PT80349A (en) 1985-05-01
GB2158825B (en) 1989-01-25
DE3514076C2 (fr) 1989-03-30
DE3514076A1 (de) 1985-10-31
JPS60228479A (ja) 1985-11-13
SE8804586L (sv) 1988-12-20
ES542584A0 (es) 1986-09-16
PT80349B (pt) 1987-09-30
AU612993B2 (en) 1991-07-25
AT390258B (de) 1990-04-10
GB8510297D0 (en) 1985-05-30
FI851637L (fi) 1985-10-27
NL8501172A (nl) 1985-11-18
FR2614620A1 (fr) 1988-11-04
DD238795A5 (de) 1986-09-03
SE463102B (sv) 1990-10-08
ZA853102B (en) 1986-12-30
ID21142A (id) 1999-04-29
FI851637A0 (fi) 1985-04-25
AU4165085A (en) 1985-10-31
RO91871B (ro) 1987-07-31

Similar Documents

Publication Publication Date Title
IT1209953B (it) Derivati di 1,4-diidro-4-ossonaftiridina e relativi sali, procedimento per la loro produzione e agenti antibatterici che comprendono i medesimi
IT8422334A0 (it) Derivati piperazinici farmacologicamente attivi e processo per la loro preparazione.
IT8521968A0 (it) Derivati di 1,2-benzisotiazol-3-ilpiperazina analgesici.
IT1217923B (it) Macchina perfezionata per la produzione di granita
IT8419543A0 (it) Derivati di 3-cefem-4-carbossilati e loro sali, esteri e solvati aventi proprieta' antibatteriche.
IT1164634B (it) Derivati cefalosporinici e composizioni antibatteriche che li contengono,nonche' procedimento per la loro produzione
IT1231760B (it) Derivati di acido piridoncarbossilico e loro sali, procedimento per produrre gli stessi e agenti antibatterici che li contengono
IT1242004B (it) Derivati di isoindolo e loro sali, procedimenti per produrli ed agenteantitumore che li contiene.
DK615186A (da) Substituerede 5,6-dialkoxyquinazolinderivater
DE3664910D1 (de) Substituted 2,3,4,9-tetrahydro-1h-carbazole-1-acetic acid derivatives
IT8225085A0 (it) Composti stilben-azo-derivati o stilben-azossi derivato,procedimenti per la loro produzioe ed il loro impiego
DK10190A (da) 1,1-dioxo-cephem-4-carbothiolsyrederivater
IT8548298A0 (it) Nuovi derivati steroidei sostituiti in posizione 11-beta, procedimento per la loro preparazione e loro applicazione come medicamenti
IT8248901A0 (it) Cotica, e procedimento per la loro derivati di spirotiazolidinil pipepreparazione razina dotati di attivita' antipsi-
IT1247696B (it) Penam-derivati e loro sali, procedimento per la loro produzione ed agente antibatterico che li contiene.
IT1185067B (it) Derivati di tiocianopirimidina,processo per la loro produzione e funghicidi per uso agricolo e orticolo che li contengono
IS3179A7 (is) Nýjar 16,17 asetalsúbstitúeraðar pregnan-21-karboxýlsýruafleiður
IT8249771A0 (it) Derivati di cicloesanone aventi attivita' diserbante, e procedimento per la loro preparazione
IT8223685A0 (it) Nuovi derivati del5-amminoisossazolo e procedimenti per la loro produzione.
IT1148404B (it) 2-fenil-2h-1,2,3-triazoli,procedimenti per la loro produzione e loro impiego
IT1231933B (it) Derivati 4 amminofenilici cicloalchil sostituiti e processo per la loro preparazione.
ES549738A0 (es) Procedimiento para la produccion de derivados de 1,4-dihi- dropiridina
FR2562074B1 (fr) Procede de preparation de derives de 2,2-bishalomethylpename
IT8622839A0 (it) 10b-alchinil-4,9(11)-estradiene derivati e procedimento per la loro preparazione.
IT1183478B (it) 13,14,19,20-tetradeidro derivati di carboprostaciline e procedimento per la loro preparazione

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970222